FD-001

· Chengdu FenDi Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FD-001, covering 2024-12-17 to 2024-12-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of FD-001 in Recurrent /Refractory (R/R)AML/NHL/MM/MDS [Phase 1]